InVitae Corp (NASDAQ:NVTA) Chairman Randal W. Scott purchased 66,666 shares of InVitae Corp stock in a transaction that occurred on Tuesday, November 22nd. The stock was acquired at an average price of $6.00 per share, with a total value of $399,996.00. Following the transaction, the chairman now owns 3,506,225 shares in the company, valued at $21,037,350. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Shares of InVitae Corp (NASDAQ:NVTA) traded up 1.91% during trading on Tuesday, reaching $6.95. 948,492 shares of the company’s stock were exchanged. InVitae Corp has a 52 week low of $5.66 and a 52 week high of $11.85. The stock’s market capitalization is $225.49 million. The company’s 50-day moving average is $7.63 and its 200 day moving average is $8.25.

InVitae Corp (NASDAQ:NVTA) last released its quarterly earnings results on Monday, November 7th. The company reported ($0.77) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.72) by $0.05. The firm had revenue of $6.30 million for the quarter, compared to analyst estimates of $7.50 million. During the same period in the prior year, the firm earned ($0.71) earnings per share. The company’s quarterly revenue was up 186.4% on a year-over-year basis. On average, analysts forecast that InVitae Corp will post ($3.02) earnings per share for the current year.

Hedge funds have recently added to or reduced their stakes in the company. SG Americas Securities LLC bought a new stake in InVitae Corp during the third quarter worth $105,000. Credit Suisse AG increased its stake in InVitae Corp by 17.2% in the third quarter. Credit Suisse AG now owns 12,528 shares of the company’s stock worth $110,000 after buying an additional 1,839 shares during the last quarter. Rhumbline Advisers bought a new stake in InVitae Corp during the second quarter worth $122,000. Metropolitan Life Insurance Co. NY bought a new stake in InVitae Corp during the second quarter worth $142,000. Finally, The Manufacturers Life Insurance Company bought a new stake in InVitae Corp during the third quarter worth $152,000.

Several analysts recently commented on the stock. Zacks Investment Research downgraded shares of InVitae Corp from a “buy” rating to a “hold” rating in a research report on Saturday. Leerink Swann initiated coverage on shares of InVitae Corp in a research report on Thursday, November 10th. They set an “outperform” rating and a $12.00 price objective for the company. Benchmark Co. restated a “neutral” rating on shares of InVitae Corp in a research report on Tuesday, November 8th. TheStreet downgraded shares of InVitae Corp from a “hold” rating to a “sell” rating in a research report on Thursday, September 15th. Finally, JPMorgan Chase & Co. upped their price objective on shares of InVitae Corp from $12.00 to $14.00 and gave the stock an “overweight” rating in a research report on Tuesday, August 9th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and two have assigned a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus price target of $10.81.

COPYRIGHT VIOLATION NOTICE: This story was first posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this story on another publication, it was stolen and reposted in violation of U.S. and international copyright & trademark law. The original version of this story can be accessed at https://www.thecerbatgem.com/2016/11/22/invitae-corp-nvta-chairman-randal-w-scott-purchases-66666-shares.html.

InVitae Corp Company Profile

Invitae Corporation (Invitae) utilizes an integrated portfolio of laboratory processes, software tools and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic variation and generate test reports for clinicians and their patients.

5 Day Chart for NASDAQ:NVTA

Receive News & Stock Ratings for InVitae Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InVitae Corp and related stocks with our FREE daily email newsletter.